Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019


Phacilitate Leaders Europe Agenda 2018


Clinicians 101: How can European ATMP manufacturers work with clinicians to safeguard patient access in a healthcare setting?

11 Sep 2018
  • Where is the greatest clinical need for ATMPs?
  • How will ATMPs work in a healthcare setting? Are specific centres of excellence the answer to getting these therapies to patients successfully?
  • Can industry collaborate with clinicians to ensure products are easier to administer? How can ATMP manufacturers further simplify the handling of CGT products in the clinic?
  • How do clinicians view hospital exemption for ATMPs?
  • 10 minute open floor discussion (to be carried on in the workshop following this session): clinicians and manufacturers to collaborate on how to gain wider patient access. What do manufacturers need from the clinicians and vice versa.
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd